What is Personalis' operating income?

Personalis' total operating income in 2025 was -$88.06 million, based on the following breakdown: Total Gross Profit: $15.78 million Total Operating Expenses: $103.83 million

Personalis (PSNL) Financials

$15.79 +0.04 (+0.25%)

Closing price 11/4/2026 04:00 PM Eastern

Extended Trading

$14.72 -1.07 (-6.74%)

As of 11/4/2026 07:36 PM Eastern

Compare

Annual Income Statements for Personalis

This table shows Personalis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-24	-20	-25	-41	-65	-113	-108	-81	-81
Consolidated Net Income / (Loss)	-24	-20	-25	-41	-65	-113	-108	-81	-81
Net Income / (Loss) Continuing Operations	-24	-20	-25	-41	-65	-113	-108	-81	-81
Total Pre-Tax Income	-24	-20	-25	-41	-65	-113	-108	-81	-81
Total Operating Income	-22	-14	-22	-42	-65	-116	-110	-68	-88
Total Gross Profit	-2.34	12	22	20	32	13	18	27	16
Total Revenue	9.39	38	65	79	85	65	73	85	70
Operating Revenue	9.39	38	65	79	85	65	73	85	70
Total Cost of Revenue	12	26	43	59	54	52	55	58	54
Operating Cost of Revenue	12	26	43	59	54	52	55	58	54
Total Operating Expenses	20	26	44	62	97	129	128	95	104
Selling, General & Admin Expense	9.90	11	22	34	48	64	50	46	54
Research & Development Expense	9.92	14	22	29	49	65	65	49	50
Total Other Income / (Expense), net	-1.43	-6.11	-2.66	0.92	0.14	2.26	1.72	-13	6.81
Interest Expense	1.30	6.55	2.84	0.00	0.18	0.20	0.11	0.02	0.21
Interest & Investment Income	0.10	0.29	1.62	0.95	0.37	2.40	5.90	5.51	7.16
Other Income / (Expense), net	-0.23	0.15	-1.44	-0.02	-0.04	0.06	-4.07	-18	-0.14
Income Tax Expense	0.01	0.01	0.01	0.06	0.01	0.04	0.08	0.02	0.02
Basic Earnings per Share	($7.78)	($6.49)	($1.39)	($1.20)	($1.49)	($2.48)	($2.25)	($1.37)	($0.91)
Weighted Average Basic Shares Outstanding	3.03M	3.06M	18.01M	34.37M	43.89M	45.70M	48.18M	59.25M	89.24M
Diluted Earnings per Share	($7.78)	($6.49)	($1.39)	($1.20)	($1.49)	($2.48)	($2.25)	($1.37)	($0.91)
Weighted Average Diluted Shares Outstanding	3.03M	3.06M	18.01M	34.37M	43.89M	45.70M	48.18M	59.25M	89.24M
Weighted Average Basic & Diluted Shares Outstanding	3.03M	3.06M	18.01M	34.37M	43.89M	46.74M	50.50M	88.26M	104.63M

This table shows Personalis' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026	9/30/2026
Total Costs & Expenses	-	-	-	-	-	-	38	-	-	-	61
Net Income / (Loss) Attributable to Common Shareholders	-13	-13	-39	-16	-16	-20	-22	-24	-30	-32	-34
Consolidated Net Income / (Loss)	-13	-13	-39	-16	-16	-20	-22	-24	-30	-32	-34
Net Income / (Loss) Continuing Operations	-13	-13	-39	-16	-16	-20	-22	-24	-30	-32	-34
Total Pre-Tax Income	-13	-13	-39	-16	-16	-20	-22	-24	-30	-32	-34
Total Operating Income	-19	-17	-14	-18	-18	-22	-23	-25	-32	-34	-36
Total Gross Profit	5.49	8.04	8.75	4.55	7.21	4.76	1.91	1.90	0.28	4.74	6.57
Total Revenue	20	23	26	17	21	17	14	17	15	22	26
Operating Revenue	20	23	26	17	21	17	14	17	15	22	26
Total Cost of Revenue	14	15	17	12	13	12	13	15	15	18	19
Operating Cost of Revenue	14	15	17	12	13	12	13	15	15	18	19
Total Operating Expenses	24	25	23	23	25	27	25	27	32	38	42
Selling, General & Admin Expense	12	12	11	11	12	14	13	14	18	22	26
Research & Development Expense	13	13	12	11	13	12	12	13	15	16	16
Impairment Charge	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Restructuring Charge	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Other Income / (Expense), net	5.92	4.10	-25	1.69	1.95	1.75	1.64	1.46	2.15	1.91	1.72
Interest Expense	0.01	0.01	0.01	-0.00	0.03	0.05	0.06	0.07	0.05	0.04	0.04
Interest & Investment Income	1.36	1.14	1.38	1.63	2.03	1.88	1.68	1.57	2.17	1.97	1.76
Other Income / (Expense), net	4.57	2.97	-26	0.06	-0.05	-0.08	0.03	-0.04	0.02	-0.02	-0.00
Income Tax Expense	0.01	0.00	0.00	0.00	0.01	0.00	0.00	0.01	0.02	0.01	0.00
Basic Earnings per Share	($0.26)	($0.24)	($0.64)	($0.23)	($0.18)	($0.23)	($0.24)	($0.26)	($0.29)	($0.30)	($0.32)
Weighted Average Basic Shares Outstanding	50.68M	52.39M	61.05M	59.25M	87.46M	88.52M	88.70M	89.24M	104.19M	105.42M	107.21M
Diluted Earnings per Share	($0.26)	($0.24)	($0.64)	($0.23)	($0.18)	($0.23)	($0.24)	($0.26)	($0.29)	($0.30)	($0.32)
Weighted Average Diluted Shares Outstanding	50.68M	52.39M	61.05M	59.25M	87.46M	88.52M	88.70M	89.24M	104.19M	105.42M	107.21M
Weighted Average Basic & Diluted Shares Outstanding	51.94M	53.07M	70.65M	88.26M	88.33M	88.68M	88.80M	104.63M	104.72M	106.80M	108.40M

This table details how cash moves in and out of Personalis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	12	-2.87	35	13	39	-16	-32	34	33
Net Cash From Operating Activities	0.29	5.57	-18	-43	-71	-70	-56	-45	-75
Net Cash From Continuing Operating Activities	0.29	5.57	-18	-43	-71	-70	-56	-45	-75
Net Income / (Loss) Continuing Operations	-24	-20	-25	-41	-65	-113	-108	-81	-81
Consolidated Net Income / (Loss)	-24	-20	-25	-41	-65	-113	-108	-81	-81
Depreciation Expense	1.22	3.07	4.75	5.76	6.01	8.43	11	11	10
Amortization Expense	-	0.00	-0.04	0.39	2.03	0.06	-2.00	-2.67	-3.99
Non-Cash Adjustments To Reconcile Net Income	1.91	6.98	9.57	9.71	17	24	29	30	10
Changes in Operating Assets and Liabilities, net	21	15	-7.26	-17	-31	11	13	-2.59	-10
Net Cash From Investing Activities	-5.16	-7.85	-82	-65	-60	53	13	-35	-23
Net Cash From Continuing Investing Activities	-5.16	-7.85	-82	-65	-60	53	13	-35	-23
Purchase of Property, Plant & Equipment	-5.16	-7.85	-8.38	-3.25	-11	-50	-11	-1.60	-4.50
Purchase of Investments	0.00	0.00	-79	-162	-267	-121	-104	-122	-210
Sale of Property, Plant & Equipment	-	-	-	-	-	-	0.00	0.24	0.00
Sale and/or Maturity of Investments	0.00	0.00	5.70	100	218	224	128	88	192
Net Cash From Financing Activities	16	-0.59	135	121	170	1.37	11	115	130
Net Cash From Continuing Financing Activities	16	-0.59	135	121	170	1.37	11	115	130
Repayment of Debt	-0.89	-0.67	-26	0.00	-1.86	-2.29	-3.26	-1.13	-2.00
Issuance of Common Equity	0.00	0.00	144	118	162	0.00	11	31	130
Other Financing Activities, net	0.07	0.08	21	4.20	9.64	3.66	3.44	85	2.40
Effect of Exchange Rate Changes	-	-	0.00	0.01	0.05	-0.13	-	-	0.01
Cash Income Taxes Paid	0.01	0.01	0.01	0.04	0.04	0.05	0.06	0.04	0.02

This table details how cash moves in and out of Personalis' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026	9/30/2026
Net Change in Cash & Equivalents	-13	3.77	28	16	-20	-18	-3.40	74	-51	20	4.30
Net Cash From Operating Activities	-20	-11	-6.20	-7.80	-18	-13	-22	-22	-22	-26	-27
Net Cash From Continuing Operating Activities	-20	-11	-6.20	-7.80	-18	-13	-22	-22	-22	-26	-27
Net Income / (Loss) Continuing Operations	-13	-13	-39	-16	-16	-20	-22	-24	-30	-32	-34
Consolidated Net Income / (Loss)	-13	-13	-39	-16	-16	-20	-22	-24	-30	-32	-34
Depreciation Expense	2.84	2.80	2.76	2.54	2.59	2.53	2.47	2.46	2.37	2.41	2.48
Amortization Expense	-0.72	-0.54	-0.56	-0.84	-1.08	-1.12	-0.94	-0.85	-1.13	-1.07	-0.77
Non-Cash Adjustments To Reconcile Net Income	-1.54	-0.16	29	-1.05	2.24	3.35	2.52	2.36	2.74	4.11	4.05
Changes in Operating Assets and Liabilities, net	-8.02	-0.04	1.61	7.97	-5.95	2.37	-4.20	-2.41	3.57	0.45	0.97
Net Cash From Investing Activities	6.30	13	-28	-26	-23	-4.37	19	-14	-46	38	24
Net Cash From Continuing Investing Activities	6.30	13	-28	-26	-23	-4.37	19	-14	-46	38	24
Purchase of Property, Plant & Equipment	-0.10	-0.01	-0.25	-1.25	-2.51	-0.29	-1.63	-0.08	-3.19	-3.78	-3.07
Purchase of Investments	-29	-8.74	-39	-45	-64	-44	-48	-54	-67	-27	-20
Sale and/or Maturity of Investments	36	22	11	20	44	40	69	39	24	69	47
Net Cash From Financing Activities	1.13	1.52	62	50	20	-0.33	-0.32	111	18	7.99	7.37
Net Cash From Continuing Financing Activities	1.13	1.52	62	50	20	-0.33	-0.32	111	18	7.99	7.37
Repayment of Debt	-0.31	-0.21	-0.31	-0.31	-0.31	-1.00	-0.41	-0.28	-1.28	-0.16	-0.08
Issuance of Common Equity	1.44	1.72	27	0.77	18	0.67	0.09	111	21	8.15	7.45
Effect of Exchange Rate Changes	-0.02	-	0.01	-	0.00	0.01	-0.00	0.00	-	-	-0.01

This table presents Personalis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	42	157	245	397	293	225	270	334
Total Current Assets	30	140	221	318	200	147	203	268
Cash & Equivalents	20	55	69	106	89	57	91	124
Short-Term Investments	0.00	73	135	181	79	57	94	116
Accounts Receivable	4.46	3.30	6.35	18	17	18	8.14	16
Inventories, net	3.43	4.61	5.64	5.61	8.59	10	5.94	6.14
Prepaid Expenses	1.93	3.38	5.44	7.09	6.81	4.36	3.93	5.65
Plant, Property, & Equipment, net	11	14	12	20	62	57	48	45
Total Noncurrent Assets	0.66	3.61	12	59	31	21	19	21
Other Noncurrent Operating Assets	0.66	3.61	12	59	31	21	19	21
Total Liabilities & Shareholders' Equity	42	157	245	397	293	225	270	334
Total Liabilities	59	51	50	86	75	96	67	73
Total Current Liabilities	58	50	41	31	33	47	31	40
Accounts Payable	6.57	7.34	8.30	9.22	13	15	6.40	13
Accrued Expenses	3.39	6.65	11	18	19	24	22	25
Current Deferred Revenue	43	-	-	-	1.26	3.29	-	1.56
Other Current Liabilities	-	36	21	3.98	0.00	5.09	3.10	0.00
Total Noncurrent Liabilities	0.80	0.64	9.26	55	41	48	36	33
Other Noncurrent Operating Liabilities	0.80	0.64	9.26	55	41	48	36	33
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-106	107	195	310	218	129	203	261
Total Preferred & Common Equity	-106	107	195	310	218	129	203	261
Preferred Stock	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-106	107	195	310	218	129	203	261
Common Stock	9.13	247	377	558	579	598	753	892
Retained Earnings	-116	-141	-182	-247	-360	-469	-550	-631
Accumulated Other Comprehensive Income / (Loss)	-0.02	-0.01	0.02	-0.17	-0.91	-0.22	-0.02	0.10

This table presents Personalis' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026	9/30/2026
Total Assets	249	227	195	186	240	273	259	243	325	312	292
Total Current Assets	161	148	120	113	170	206	193	174	258	245	223
Cash & Equivalents	97	72	44	48	76	71	53	50	74	94	98
Short-Term Investments	40	48	51	39	68	115	120	101	160	119	92
Accounts Receivable	10	14	11	13	13	11	9.95	14	13	15	18
Inventories, net	8.14	8.23	8.77	9.16	8.49	4.92	5.44	4.66	6.93	9.64	7.38
Prepaid Expenses	5.48	5.66	4.91	4.05	4.66	4.84	4.72	4.86	5.03	7.65	7.03
Plant, Property, & Equipment, net	59	57	55	53	50	48	46	47	48	49	50
Total Noncurrent Assets	29	22	20	20	19	19	20	21	19	19	18
Other Noncurrent Operating Assets	29	22	20	20	19	19	20	21	19	19	18
Total Liabilities & Shareholders' Equity	249	227	195	186	240	273	259	243	325	312	292
Total Liabilities	73	75	75	73	73	66	68	71	71	77	79
Total Current Liabilities	29	32	31	34	36	30	32	36	39	46	49
Accounts Payable	8.85	8.96	9.18	9.94	12	7.91	9.93	11	13	16	14
Accrued Expenses	16	20	16	19	21	20	20	24	22	27	33
Current Deferred Revenue	-	-	3.53	4.17	3.43	1.96	1.63	-	4.17	3.40	1.65
Other Current Liabilities	3.34	3.69	2.51	0.78	0.00	0.00	0.00	1.46	0.00	0.00	0.00
Total Noncurrent Liabilities	44	43	43	39	37	36	36	35	32	31	30
Other Noncurrent Operating Liabilities	44	43	43	39	37	36	36	35	32	31	30
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	176	151	121	112	167	207	191	171	255	235	213
Total Preferred & Common Equity	176	151	121	112	167	207	191	171	255	235	213
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	176	151	121	112	167	207	191	171	255	235	213
Common Stock	589	594	602	607	700	773	777	779	916	928	940
Retained Earnings	-413	-442	-482	-494	-534	-566	-586	-607	-661	-693	-727
Accumulated Other Comprehensive Income / (Loss)	-0.31	-0.30	-0.13	-0.12	0.09	-0.02	0.02	0.08	-0.07	-0.12	-0.17

This table displays calculated financial ratios and metrics derived from Personalis' official financial filings.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	0.00	0.00	31,233,959.00	38,932,805.00	44,783,861.00	45,971,355.00	49,031,396.00	-	88,804,348.00
DEI Adjusted Shares Outstanding	0.00	0.00	31,233,959.00	38,932,805.00	44,783,861.00	45,971,355.00	49,031,396.00	-	88,804,348.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	0.00	-0.80	-1.06	-1.46	-2.46	-2.21	-	-0.92
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	302.15%	72.62%	20.61%	8.70%	-23.92%	12.97%	15.15%	-17.69%
EBITDA Growth	0.00%	50.16%	-81.44%	-88.11%	-59.21%	-86.54%	2.12%	25.05%	-4.67%
EBIT Growth	0.00%	39.17%	-75.17%	-76.75%	-55.07%	-76.57%	1.27%	23.90%	-1.67%
NOPAT Growth	0.00%	37.87%	-62.80%	-88.00%	-55.06%	-76.78%	4.84%	37.90%	-28.99%
Net Income Growth	0.00%	15.73%	-26.14%	-64.57%	-58.01%	-73.73%	4.43%	24.94%	0.02%
EPS Growth	0.00%	16.58%	78.58%	13.67%	-24.17%	-66.44%	9.27%	39.11%	33.58%
Operating Cash Flow Growth	0.00%	1,821.38%	-424.28%	-136.06%	-66.06%	0.84%	19.90%	19.74%	-65.99%
Free Cash Flow Firm Growth	0.00%	0.00%	-216.89%	-65.56%	-80.86%	-39.81%	61.40%	-20.93%	-28.63%
Invested Capital Growth	0.00%	0.00%	31.93%	61.36%	378.45%	117.24%	-69.77%	17.60%	18.30%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	2.64%	0.60%	-5.74%	4.19%	-3.29%	0.79%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	-18.70%	-12.90%	-11.90%	3.49%	10.69%	-9.81%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-17.16%	-11.65%	-11.54%	3.49%	10.33%	-8.96%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-17.16%	-11.72%	-11.44%	6.87%	7.91%	-8.84%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-19.36%	-11.75%	-10.61%	3.98%	11.11%	-10.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-269.01%	-7.97%	-9.25%	5.46%	18.45%	-3.41%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-4.62%	-13.09%	-21.94%	-2.16%	5.61%	11.07%	-23.89%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-21.71%	-5.84%	34.31%	-13.53%	-19.30%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-230.76%	15.80%	1.69%	-50.03%	-22.34%	1.59%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	-24.94%	31.25%	33.86%	25.57%	37.03%	20.52%	24.78%	31.70%	22.65%
EBITDA Margin	-225.42%	-27.94%	-29.37%	-45.80%	-67.08%	-164.47%	-142.50%	-92.75%	-117.94%
Operating Margin	-235.95%	-36.45%	-34.38%	-53.59%	-76.44%	-177.61%	-149.61%	-80.68%	-126.43%
EBIT Margin	-238.37%	-36.06%	-36.59%	-53.62%	-76.49%	-177.52%	-155.15%	-102.53%	-126.64%
Profit (Net Income) Margin	-251.23%	-52.64%	-38.47%	-52.49%	-76.29%	-174.20%	-147.38%	-96.06%	-116.69%
Tax Burden Percent	100.02%	100.04%	100.04%	100.14%	100.02%	100.04%	100.08%	100.02%	100.03%
Interest Burden Percent	105.37%	145.95%	105.10%	97.75%	99.72%	98.10%	94.92%	93.68%	92.12%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	-614.38%	-219.41%	-234.11%	-287.79%	-314.65%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	-606.44%	-205.14%	-211.87%	-265.39%	-305.41%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	588.57%	176.52%	171.79%	238.88%	279.63%
Return on Equity (ROE)	0.00%	117.09%	-55.92%	-27.37%	-25.82%	-42.89%	-62.31%	-48.91%	-35.02%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	-332.78%	-293.32%	-126.97%	-303.96%	-331.41%
Operating Return on Assets (OROA)	0.00%	-32.69%	-23.98%	-20.97%	-20.39%	-33.51%	-44.03%	-35.03%	-29.18%
Return on Assets (ROA)	0.00%	-47.72%	-25.22%	-20.53%	-20.34%	-32.88%	-41.83%	-32.82%	-26.89%
Return on Common Equity (ROCE)	0.00%	733.43%	-0.19%	-27.37%	-25.82%	-42.89%	-62.31%	-48.91%	-35.02%
Return on Equity Simple (ROE_SIMPLE)	0.00%	18.69%	-23.51%	-21.18%	-21.02%	-51.95%	-83.66%	-40.05%	0.00%
Net Operating Profit after Tax (NOPAT)	-16	-9.64	-16	-30	-46	-81	-77	-48	-62
NOPAT Margin	-165.17%	-25.52%	-24.07%	-37.51%	-53.51%	-124.33%	-104.73%	-56.48%	-88.50%
Net Nonoperating Expense Percent (NNEP)	0.00%	-138.96%	-13.13%	-7.10%	-7.94%	-14.27%	-22.24%	-22.39%	-9.24%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-59.45%	-23.55%	-23.60%
Cost of Revenue to Revenue	124.94%	68.75%	66.14%	74.43%	62.97%	79.48%	75.22%	68.30%	77.35%
SG&A Expenses to Revenue	105.41%	29.84%	33.86%	42.84%	55.79%	98.34%	67.67%	54.59%	76.92%
R&D to Revenue	105.60%	37.87%	34.38%	36.32%	57.68%	99.79%	88.15%	57.80%	72.17%
Operating Expenses to Revenue	211.01%	67.71%	68.24%	79.16%	113.47%	198.14%	174.39%	112.38%	149.08%
Earnings before Interest and Taxes (EBIT)	-22	-14	-24	-42	-65	-115	-114	-87	-88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-21	-11	-19	-36	-57	-107	-105	-78	-82
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	3.19	7.31	2.06	0.42	0.80	2.01	2.71
Price to Tangible Book Value (P/TBV)	0.00	0.00	3.19	7.31	2.06	0.42	0.80	2.01	2.71
Price to Revenue (P/Rev)	14.34	3.57	5.22	18.12	7.48	1.40	1.40	4.83	10.15
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	15.15	0.00	0.00	12.44	21.99
Enterprise Value to Revenue (EV/Rev)	0.00	5.54	3.25	15.54	4.12	0.00	0.00	2.64	6.70
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	37.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	-0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.00	0.87	-1.59	-1.10	-0.97	-0.86	-0.81	-0.90	-0.92
Leverage Ratio	0.00	-2.45	2.22	1.33	1.27	1.30	1.49	1.49	1.30
Compound Leverage Factor	0.00	-3.58	2.33	1.30	1.27	1.28	1.41	1.40	1.20
Debt to Total Capital	0.00%	-41.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	-41.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	-745.78%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	887.45%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	-0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	-0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	-3.49	3.38	16.73	4.11	-1.39	-3.08	0.81	3.32
Noncontrolling Interest Sharing Ratio	0.00%	-526.40%	99.66%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.51	2.79	5.43	10.16	6.03	3.11	6.52	6.76
Quick Ratio	0.00	0.42	2.63	5.16	9.76	5.56	2.79	6.21	6.46
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	22	-26	-43	-77	-108	-42	-50	-65
Operating Cash Flow to CapEx	5.62%	70.96%	-215.57%	-1,314.02%	-639.07%	-140.76%	-515.61%	-3,317.41%	-1,663.99%
Free Cash Flow to Firm to Interest Expense	0.00	3.37	-9.10	-21,378.10	-420.27	-537.89	-379.42	-2,103.04	-316.70
Operating Cash Flow to Interest Expense	0.22	0.85	-6.37	-21,326.50	-384.93	-349.42	-511.44	-1,881.25	-365.59
Operating Cash Flow Less CapEx to Interest Expense	-3.74	-0.35	-9.32	-22,949.50	-445.17	-597.66	-610.63	-1,937.96	-387.56
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.91	0.66	0.39	0.27	0.19	0.28	0.34	0.23
Accounts Receivable Turnover	0.00	8.48	16.81	16.30	6.89	3.71	4.28	6.54	5.72
Inventory Turnover	0.00	7.57	10.73	11.43	9.57	7.28	5.80	7.04	8.92
Fixed Asset Turnover	0.00	3.30	5.10	6.06	5.43	1.59	1.23	1.60	1.50
Accounts Payable Turnover	0.00	3.96	6.20	7.49	6.15	4.68	3.98	5.42	5.56
Days Sales Outstanding (DSO)	0.00	43.07	21.71	22.39	52.98	98.51	85.37	55.80	63.79
Days Inventory Outstanding (DIO)	0.00	48.24	34.01	31.94	38.13	50.13	62.95	51.83	40.93
Days Payable Outstanding (DPO)	0.00	92.27	58.83	48.76	59.40	77.93	91.70	67.32	65.67
Cash Conversion Cycle (CCC)	0.00	-0.97	-3.10	5.58	31.71	70.71	56.61	40.31	39.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	-32	-22	-8.35	23	50	15	18	21
Invested Capital Turnover	0.00	-2.38	-2.45	-5.25	11.48	1.76	2.24	5.10	3.56
Increase / (Decrease) in Invested Capital	0.00	-32	10	13	32	27	-35	2.69	3.28
Enterprise Value (EV)	0.00	209	212	1,222	352	-77	-11	223	467
Market Capitalization	135	135	340	1,425	639	91	103	408	707
Book Value per Share	$0.00	($34.73)	$3.42	$5.01	$6.93	$4.75	$2.64	$2.87	$2.94
Tangible Book Value per Share	$0.00	($34.73)	$3.42	$5.01	$6.93	$4.75	$2.64	$2.87	$2.94
Total Capital	0.00	-12	107	195	310	218	129	203	261
Total Debt	0.00	5.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	0.00	-15	-128	-203	-287	-168	-114	-185	-240
Capital Expenditures (CapEx)	5.16	7.85	8.38	3.25	11	50	11	1.36	4.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-43	-39	-23	-0.15	-1.09	-15	-13	-12
Debt-free Net Working Capital (DFNWC)	0.00	-23	90	180	287	167	100	172	228
Net Working Capital (NWC)	0.00	-28	90	180	287	167	100	172	228
Net Nonoperating Expense (NNE)	8.08	10	9.39	12	19	32	31	33	20
Net Nonoperating Obligations (NNO)	0.00	-15	-128	-203	-287	-168	-114	-185	-240
Total Depreciation and Amortization (D&A)	1.22	3.07	4.71	6.15	8.05	8.49	9.30	8.27	6.06
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-113.94%	-59.31%	-29.51%	-0.17%	-1.68%	-19.96%	-15.51%	-16.70%
Debt-free Net Working Capital to Revenue	0.00%	-61.67%	137.43%	228.97%	335.60%	256.07%	135.42%	203.14%	327.82%
Net Working Capital to Revenue	0.00%	-74.90%	137.43%	228.97%	335.60%	256.07%	135.42%	203.14%	327.82%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($7.78)	($6.49)	($1.39)	($1.20)	($1.49)	($2.48)	($2.25)	($1.37)	($0.91)
Adjusted Weighted Average Basic Shares Outstanding	3.03M	3.06M	31.47M	43.69M	44.95M	45.70M	48.18M	59.25M	89.24M
Adjusted Diluted Earnings per Share	($7.78)	($6.49)	($1.39)	($1.20)	($1.49)	($2.48)	($2.25)	($1.37)	($0.91)
Adjusted Weighted Average Diluted Shares Outstanding	3.03M	3.06M	31.47M	43.69M	44.95M	45.70M	48.18M	59.25M	89.24M
Adjusted Basic & Diluted Earnings per Share	($7.78)	($6.49)	($1.39)	($1.20)	($1.49)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	3.03M	3.06M	18.01M	34.37M	43.89M	46.74M	50.50M	88.26M	104.63M
Normalized Net Operating Profit after Tax (NOPAT)	-16	-9.64	-16	-30	-46	-81	-67	-48	-62
Normalized NOPAT Margin	-165.17%	-25.52%	-24.07%	-37.51%	-53.51%	-124.33%	-91.73%	-56.48%	-88.50%
Pre Tax Income Margin	-251.18%	-52.63%	-38.45%	-52.41%	-76.28%	-174.14%	-147.27%	-96.04%	-116.66%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-17.18	-2.08	-8.41	-21,085.00	-355.41	-574.48	-1,036.40	-3,614.67	-430.24
NOPAT to Interest Expense	-11.91	-1.47	-5.53	-14,751.10	-248.63	-402.35	-699.59	-1,991.12	-300.68
EBIT Less CapEx to Interest Expense	-21.14	-3.28	-11.36	-22,708.00	-415.64	-822.72	-1,135.59	-3,671.38	-452.21
NOPAT Less CapEx to Interest Expense	-15.87	-2.67	-8.49	-16,374.10	-308.86	-650.59	-798.78	-2,047.83	-322.65
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-16.73%	-1.05%	-0.52%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Personalis' official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026	9/30/2026
DEI Shares Outstanding	50,503,889.00	51,938,839.00	53,074,698.00	-	88,263,269.00	88,325,138.00	88,677,062.00	88,804,348.00	104,631,832.00	104,721,098.00	106,799,872.00
DEI Adjusted Shares Outstanding	50,503,889.00	51,938,839.00	53,074,698.00	-	88,263,269.00	88,325,138.00	88,677,062.00	88,804,348.00	104,631,832.00	104,721,098.00	106,799,872.00
DEI Earnings Per Adjusted Shares Outstanding	-0.26	-0.25	-0.74	-	-0.18	-0.23	-0.24	-0.27	-0.29	-0.30	-0.32
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.53%	35.22%	40.89%	-14.61%	5.53%	-23.81%	-43.62%	3.24%	-24.91%	29.96%	76.59%
EBITDA Growth	55.58%	48.95%	-33.51%	36.48%	-33.14%	-75.54%	43.19%	-44.89%	-90.25%	-57.57%	-55.52%
EBIT Growth	52.06%	45.06%	-31.54%	35.63%	-23.97%	-57.16%	42.50%	-40.19%	-81.16%	-53.57%	-52.68%
NOPAT Growth	36.70%	33.35%	53.29%	24.45%	6.27%	-29.07%	-61.95%	-39.50%	-81.74%	-54.06%	-52.50%
Net Income Growth	54.75%	46.56%	-34.34%	38.21%	-21.45%	-56.66%	44.61%	-44.97%	-90.68%	-57.97%	-56.11%
EPS Growth	57.38%	52.00%	-6.67%	57.41%	30.77%	4.17%	62.50%	-13.04%	-61.11%	-30.43%	-33.33%
Operating Cash Flow Growth	-29.65%	-3.16%	62.84%	41.90%	12.01%	-20.40%	-251.79%	-185.35%	-25.15%	-99.23%	-24.16%
Free Cash Flow Firm Growth	113.66%	106.88%	-7.30%	-183.33%	-241.39%	-531.03%	-434.99%	-36.49%	-155.47%	-275.93%	-84.70%
Invested Capital Growth	-43.45%	-34.93%	-24.34%	17.60%	-14.31%	-30.45%	-9.56%	18.30%	-0.51%	27.88%	5.59%
Revenue Q/Q Growth	-0.76%	15.65%	13.86%	-34.65%	22.65%	-16.51%	-15.74%	19.66%	-10.80%	44.50%	14.49%
EBITDA Q/Q Growth	52.61%	4.38%	-228.11%	57.27%	0.69%	-26.07%	-6.19%	-8.97%	-30.41%	-4.42%	-4.81%
EBIT Q/Q Growth	48.97%	2.70%	-190.58%	55.38%	1.72%	-23.35%	-6.31%	-8.78%	-27.00%	-4.56%	-5.70%
NOPAT Q/Q Growth	21.24%	10.52%	14.86%	-25.94%	2.30%	-23.21%	-6.82%	-8.48%	-27.29%	-4.45%	-5.74%
Net Income Q/Q Growth	51.22%	1.28%	-205.34%	57.98%	4.11%	-27.34%	-7.96%	-9.98%	-26.12%	-5.50%	-6.69%
EPS Q/Q Growth	51.85%	7.69%	-166.67%	64.06%	21.74%	-27.78%	-4.35%	-8.33%	-11.54%	-3.45%	-6.67%
Operating Cash Flow Q/Q Growth	-52.13%	47.37%	42.31%	-25.78%	-130.39%	27.98%	-68.57%	-2.03%	-1.04%	-14.65%	-5.05%
Free Cash Flow Firm Q/Q Growth	-66.36%	-71.72%	-250.20%	-483.22%	42.93%	13.79%	-86.43%	-48.79%	-6.83%	-26.86%	8.41%
Invested Capital Q/Q Growth	65.61%	0.10%	-8.66%	-22.34%	20.67%	-18.75%	18.77%	1.59%	1.48%	4.44%	-1.93%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.13%	35.59%	34.02%	27.08%	34.98%	27.65%	13.20%	10.95%	1.82%	21.21%	25.67%
EBITDA Margin	-62.47%	-51.65%	-148.85%	-97.33%	-78.81%	-119.01%	-149.99%	-136.59%	-199.68%	-144.29%	-132.10%
Operating Margin	-96.70%	-74.81%	-55.94%	-107.81%	-85.88%	-126.75%	-160.68%	-145.67%	-207.87%	-150.25%	-138.76%
EBIT Margin	-73.30%	-61.67%	-157.39%	-107.46%	-86.11%	-127.21%	-160.50%	-145.91%	-207.74%	-150.32%	-138.78%
Profit (Net Income) Margin	-66.42%	-56.70%	-152.04%	-97.77%	-76.44%	-116.58%	-149.38%	-137.28%	-194.11%	-141.71%	-132.06%
Tax Burden Percent	100.05%	100.03%	100.01%	100.02%	100.04%	100.01%	100.01%	100.04%	100.05%	100.02%	100.01%
Interest Burden Percent	90.57%	91.91%	96.60%	90.96%	88.73%	91.64%	93.05%	94.05%	93.39%	94.26%	95.15%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-143.46%	-130.60%	-127.71%	-384.56%	-219.54%	-332.23%	-353.22%	-362.52%	-434.56%	-365.45%	-365.18%
ROIC Less NNEP Spread (ROIC-NNEP)	-143.66%	-129.73%	-105.75%	-382.05%	-217.15%	-328.55%	-349.58%	-359.64%	-430.97%	-361.22%	-359.94%
Return on Net Nonoperating Assets (RNNOA)	111.68%	100.86%	87.91%	343.88%	186.08%	282.05%	304.09%	329.28%	390.68%	327.22%	319.67%
Return on Equity (ROE)	-31.78%	-29.75%	-39.80%	-40.68%	-33.46%	-50.18%	-49.13%	-33.24%	-43.88%	-38.24%	-45.51%
Cash Return on Invested Capital (CROIC)	-142.57%	-155.18%	-165.72%	-303.96%	-184.69%	-199.05%	-247.32%	-331.41%	-331.71%	-423.55%	-417.72%
Operating Return on Assets (OROA)	-23.25%	-22.71%	-59.03%	-36.71%	-31.49%	-46.00%	-45.95%	-33.63%	-44.77%	-36.69%	-41.95%
Return on Assets (ROA)	-21.07%	-20.88%	-57.03%	-33.40%	-27.96%	-42.16%	-42.77%	-31.64%	-41.83%	-34.59%	-39.92%
Return on Common Equity (ROCE)	-31.78%	-29.75%	-39.80%	-40.68%	-33.46%	-50.18%	-49.13%	-33.24%	-43.88%	-38.24%	-45.51%
Return on Equity Simple (ROE_SIMPLE)	-76.73%	0.00%	0.00%	0.00%	-40.54%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-13	-12	-10	-13	-12	-15	-16	-18	-23	-24	-25
NOPAT Margin	-67.69%	-52.37%	-39.16%	-75.47%	-60.12%	-88.72%	-112.48%	-101.97%	-145.51%	-105.17%	-97.13%
Net Nonoperating Expense Percent (NNEP)	0.20%	-0.87%	-21.96%	-2.50%	-2.39%	-3.68%	-3.64%	-2.88%	-3.59%	-4.23%	-5.24%
Return On Investment Capital (ROIC_SIMPLE)	-10.95%	-10.53%	-6.04%	-6.25%	-5.97%	-8.00%	-9.51%	-6.77%	-8.84%	-10.00%	-11.69%
Cost of Revenue to Revenue	71.87%	64.41%	65.98%	72.92%	65.02%	72.35%	86.80%	89.05%	98.18%	78.79%	74.33%
SG&A Expenses to Revenue	59.42%	53.02%	44.51%	66.48%	59.51%	82.42%	89.92%	81.26%	115.71%	98.39%	101.63%
R&D to Revenue	65.41%	57.38%	45.44%	68.42%	61.34%	71.97%	83.97%	75.36%	93.97%	73.07%	62.80%
Operating Expenses to Revenue	124.83%	110.41%	89.96%	134.89%	120.86%	154.39%	173.89%	156.62%	209.68%	171.46%	164.43%
Earnings before Interest and Taxes (EBIT)	-14	-14	-40	-18	-18	-22	-23	-25	-32	-34	-36
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-12	-12	-38	-16	-16	-20	-22	-24	-31	-32	-34
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.62	0.54	1.71	2.01	1.49	3.04	3.37	2.71	2.62	5.97	8.18
Price to Tangible Book Value (P/TBV)	0.62	0.54	1.71	2.01	1.49	3.04	3.37	2.71	2.62	5.97	8.18
Price to Revenue (P/Rev)	1.01	0.76	3.26	4.83	3.62	7.21	8.37	10.15	10.33	20.14	21.53
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	6.14	12.44	5.73	23.08	20.46	21.99	20.11	52.91	70.15
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	1.62	2.64	1.45	5.06	6.19	6.70	6.72	17.09	19.17
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.78	-0.78	-0.83	-0.90	-0.86	-0.86	-0.87	-0.92	-0.91	-0.91	-0.89
Leverage Ratio	1.49	1.51	1.47	1.49	1.43	1.47	1.43	1.30	1.30	1.34	1.39
Compound Leverage Factor	1.35	1.39	1.42	1.36	1.27	1.34	1.33	1.22	1.21	1.26	1.32
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	-2.16	-2.54	-0.29	1.65	0.79	2.73	2.01	3.95	3.50	8.46	10.32
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.84	3.31	4.68	6.52	6.91	6.09	4.82	6.76	6.61	5.28	4.53
Quick Ratio	3.40	2.93	4.32	6.21	6.58	5.77	4.56	6.46	6.31	4.91	4.23
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	6.20	1.75	-2.63	-15	-8.77	-7.56	-14	-21	-22	-28	-26
Operating Cash Flow to CapEx	-19,627.88%	0.00%	-2,509.31%	-626.69%	-715.29%	-4,460.34%	-1,340.96%	-28,890.91%	-731.71%	-681.39%	-880.96%
Free Cash Flow to Firm to Interest Expense	689.11	194.88	-376.34	0.00	-313.19	-157.50	-220.21	-322.62	-476.65	-768.10	-723.07
Operating Cash Flow to Interest Expense	-2,268.11	-1,193.67	-885.43	0.00	-641.46	-269.48	-340.69	-342.25	-478.26	-696.49	-752.00
Operating Cash Flow Less CapEx to Interest Expense	-2,279.67	-1,167.67	-920.71	0.00	-731.14	-275.52	-366.09	-343.43	-543.62	-798.70	-837.36
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.32	0.37	0.38	0.34	0.37	0.36	0.29	0.23	0.22	0.24	0.30
Accounts Receivable Turnover	5.04	6.94	6.45	6.54	7.68	7.02	4.96	5.72	5.38	5.56	4.98
Inventory Turnover	6.50	6.68	7.18	7.04	8.35	7.54	7.71	8.92	9.39	8.07	11.18
Fixed Asset Turnover	1.28	1.43	1.64	1.60	1.67	1.63	1.42	1.50	1.34	1.48	1.66
Accounts Payable Turnover	5.49	6.16	5.60	5.42	6.69	5.54	4.30	5.56	5.41	4.69	5.25
Days Sales Outstanding (DSO)	72.48	52.57	56.61	55.80	47.53	51.97	73.55	63.79	67.88	65.63	73.23
Days Inventory Outstanding (DIO)	56.18	54.63	50.83	51.83	43.71	48.39	47.34	40.93	38.86	45.22	32.66
Days Payable Outstanding (DPO)	66.50	59.29	65.12	67.32	54.58	65.84	84.98	65.67	67.51	77.80	69.54
Cash Conversion Cycle (CCC)	62.16	47.90	42.32	40.31	36.66	34.53	35.91	39.05	39.23	33.05	36.35
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	25	25	23	18	22	18	21	21	22	23	22
Invested Capital Turnover	2.12	2.49	3.26	5.10	3.65	3.74	3.14	3.56	2.99	3.47	3.76
Increase / (Decrease) in Invested Capital	-19	-14	-7.43	2.69	-3.62	-7.70	-2.21	3.28	-0.11	4.91	1.17
Enterprise Value (EV)	-20	-26	142	223	124	406	428	467	433	1,191	1,548
Market Capitalization	75	61	286	408	310	579	578	707	667	1,403	1,739
Book Value per Share	$2.39	$2.16	$3.14	$2.87	$2.35	$2.16	$1.93	$2.94	$2.43	$2.25	$1.99
Tangible Book Value per Share	$2.39	$2.16	$3.14	$2.87	$2.35	$2.16	$1.93	$2.94	$2.43	$2.25	$1.99
Total Capital	121	112	167	203	207	191	171	261	255	235	213
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-95	-87	-144	-185	-186	-173	-151	-240	-233	-213	-191
Capital Expenditures (CapEx)	0.10	-0.23	0.25	1.24	2.51	0.29	1.63	0.08	3.07	3.78	3.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-6.35	-8.00	-9.79	-13	-9.16	-12	-12	-12	-14	-14	-17
Debt-free Net Working Capital (DFNWC)	89	79	134	172	177	162	138	228	219	199	174
Net Working Capital (NWC)	89	79	134	172	177	162	138	228	219	199	174
Net Nonoperating Expense (NNE)	-0.25	0.98	29	3.75	3.36	4.79	5.35	6.13	7.52	8.17	8.94
Net Nonoperating Obligations (NNO)	-95	-87	-144	-185	-186	-173	-151	-240	-233	-213	-191
Total Depreciation and Amortization (D&A)	2.11	2.26	2.20	1.70	1.50	1.41	1.52	1.62	1.25	1.35	1.71
Debt-free, Cash-free Net Working Capital to Revenue	-8.57%	-10.00%	-11.19%	-15.51%	-10.69%	-14.46%	-17.75%	-16.70%	-21.80%	-20.08%	-20.83%
Debt-free Net Working Capital to Revenue	120.12%	98.68%	153.01%	203.14%	206.00%	201.23%	200.06%	327.82%	339.69%	285.16%	215.15%
Net Working Capital to Revenue	120.12%	98.68%	153.01%	203.14%	206.00%	201.23%	200.06%	327.82%	339.69%	285.16%	215.15%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.26)	($0.24)	($0.64)	($0.23)	($0.18)	($0.23)	($0.24)	($0.26)	($0.29)	($0.30)	($0.32)
Adjusted Weighted Average Basic Shares Outstanding	50.68M	52.39M	61.05M	59.25M	87.46M	88.52M	88.70M	89.24M	104.19M	105.42M	107.21M
Adjusted Diluted Earnings per Share	($0.26)	($0.24)	($0.64)	($0.23)	($0.18)	($0.23)	($0.24)	($0.26)	($0.29)	($0.30)	($0.32)
Adjusted Weighted Average Diluted Shares Outstanding	50.68M	52.39M	61.05M	59.25M	87.46M	88.52M	88.70M	89.24M	104.19M	105.42M	107.21M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	51.94M	53.07M	70.65M	88.26M	88.33M	88.68M	88.80M	104.63M	104.72M	106.80M	108.40M
Normalized Net Operating Profit after Tax (NOPAT)	-13	-12	-10	-13	-12	-15	-16	-18	-23	-24	-25
Normalized NOPAT Margin	-67.69%	-52.37%	-39.16%	-75.47%	-60.12%	-88.72%	-112.48%	-101.97%	-145.51%	-105.17%	-97.13%
Pre Tax Income Margin	-66.38%	-56.68%	-152.03%	-97.74%	-76.40%	-116.57%	-149.35%	-137.23%	-194.00%	-141.69%	-132.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1,590.11	-1,547.22	-5,780.43	0.00	-633.64	-455.92	-363.52	-389.35	-683.85	-908.30	-986.72
NOPAT to Interest Expense	-1,468.44	-1,313.90	-1,438.20	0.00	-442.40	-317.98	-254.75	-272.10	-478.99	-635.51	-690.63
EBIT Less CapEx to Interest Expense	-1,601.67	-1,521.22	-5,815.71	0.00	-723.32	-461.96	-388.92	-390.54	-749.21	-1,010.51	-1,072.08
NOPAT Less CapEx to Interest Expense	-1,480.00	-1,287.90	-1,473.49	0.00	-532.08	-324.02	-280.15	-273.28	-544.36	-737.72	-775.99
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Personalis (NASDAQ:PSNL) continues to show strong liquidity, but its operating performance has weakened. The company has generated recurring net losses and negative operating cash flow across the reported periods, while recent revenue growth has not translated into improved profitability.

Large liquidity position: As of June 30, 2026, Personalis held $93.97 million in cash and $118.69 million in short-term investments, or approximately $212.66 million in combined cash and investments. This was substantially above the approximately $143.3 million held at the end of the second quarter of 2023.
Strong short-term balance-sheet coverage: Total current assets of $245.05 million compared with current liabilities of $46.39 million, implying a current ratio of roughly 5.3. Total liabilities of $76.97 million were also well below total assets of $312.14 million.
Revenue recovered year over year: Second-quarter 2026 revenue rose to $22.36 million from $17.20 million in the second quarter of 2025, an increase of approximately 30%. Revenue was also higher than the $15.47 million recorded in the first quarter of 2026.
Investment income remains helpful: Interest and investment income contributed $1.97 million in the second quarter of 2026, partially offsetting operating losses. Personalis has consistently generated roughly $1.1 million to $2.2 million of quarterly investment income in the reported periods.
Cash increased during the latest quarter: Cash and equivalents rose from $73.59 million in the first quarter of 2026 to $93.97 million in the second quarter. However, the increase was driven largely by $69.10 million of investment maturities and $8.15 million of equity issuance, rather than by profitable operations.
Gross margin has fluctuated considerably: Second-quarter gross margin was approximately 21.2%, down from 27.6% a year earlier and 35.6% in the second quarter of 2024. This compares with 28.7% in the second quarter of 2023, indicating inconsistent service economics.
Operating losses remain substantial: Personalis reported a second-quarter 2026 operating loss of $33.59 million and a net loss of $31.68 million, or $0.30 per share. The net loss was larger than the $20.06 million loss reported in the second quarter of 2025 and the $30.03 million loss in the first quarter of 2026.
Expenses are rising faster than revenue: Second-quarter 2026 operating expenses reached $38.33 million, including $22.00 million of selling, general and administrative expense and $16.34 million of research and development expense. Operating expenses were up from $26.56 million in the second quarter of 2025, despite revenue increasing by only $5.15 million.
Operating cash burn has accelerated: Net cash used in operating activities increased to $25.77 million in the second quarter of 2026 from $12.94 million in the second quarter of 2025. Personalis has reported negative operating cash flow in each supplied quarterly period, making continued access to its cash reserves important.
Share dilution is a growing concern: Weighted-average basic shares outstanding increased to 105.42 million in the second quarter of 2026 from 88.52 million in the second quarter of 2025. The company raised $8.15 million through common-equity issuance in the latest quarter, following a much larger $111.26 million equity raise in the fourth quarter of 2025.

Overall, Personalis has a sizable cash cushion and limited balance-sheet pressure, which may give management time to pursue growth initiatives. However, the company remains dependent on its reserves and periodic equity financing while revenue growth, gross margins and operating expense control have yet to produce a path toward profitability. The key indicators for investors are whether revenue gains can improve gross margins and reduce the company’s approximately $25 million-per-quarter operating cash burn.

11/05/26 05:36 AM ETAI Generated. May Contain Errors.

Personalis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Personalis' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Personalis' net income appears to be on a downward trend, with a most recent value of -$81.27 million in 2025, falling from -$23.60 million in 2017. The previous period was -$81.28 million in 2024. View Personalis' forecast to see where analysts expect Personalis to go next.

Personalis' total operating income in 2025 was -$88.06 million, based on the following breakdown:

Total Gross Profit: $15.78 million
Total Operating Expenses: $103.83 million

Over the last 8 years, Personalis' total revenue changed from $9.39 million in 2017 to $69.65 million in 2025, a change of 641.5%.

In the past 13 quarters, Personalis' cash and equivalents has ranged from $43.98 million in Q1 2024 to $98.27 million in Q3 2026, and is currently $98.27 million as of their latest financial filing in Q3 2026.

Personalis had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2017.

Over the last 8 years, Personalis' book value per share changed from 0.00 in 2017 to 2.94 in 2025, a change of 294.1%.

Related Companies

Financial statements for NASDAQ:PSNL last updated on 11/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Personalis (PSNL) Financials

Financials Breakdown Chart

Key Financial Trends

Personalis Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Personalis (PSNL) Financials

Annual Income Statements for Personalis

Quarterly Income Statements for Personalis

Annual Cash Flow Statements for Personalis

Quarterly Cash Flow Statements for Personalis

Annual Balance Sheets for Personalis

Quarterly Balance Sheets for Personalis

Annual Metrics And Ratios for Personalis

Quarterly Metrics And Ratios for Personalis

Financials Breakdown Chart

Key Financial Trends

Personalis Financials - Frequently Asked Questions

When does Personalis' fiscal year end?

How has Personalis' net income changed over the last 8 years?

What is Personalis' operating income?

How has Personalis' revenue changed over the last 8 years?

How much cash does Personalis have?

How much debt does Personalis have?

How has Personalis' book value per share changed over the last 8 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools